NHS England 26 November 2015
- This guidance on meeting Excess Treatment Costs resulting from research relates specifically to non-commercial research (i.e. research funded by the National Institute of Health Research (NIHR), other areas of central Government including Research Councils, NIHR noncommercial Partners and also Investigator-initiated, commercial-collaborative studies (Industry-funded, non-industry sponsored studies).
- It covers meeting the costs of research, excess Treatment Costs, excess Treatment Savings and responsibilities of commissioners, providers and researchers.
